Assessment of delivery of nice approved use of tolvaptan (Jinarc) in adults with autosomal dominant polycystic kidney disease in a UK renal centre

Authors
Category Primary study
JournalNephrology Dialysis Transplantation
Year 2020
This article has no abstract
Epistemonikos ID: d230242137e9a3dd4cd0025ac200f649cb44990a
First added on: Feb 12, 2025